Relevance of Subcarinal Lymph Node Dissection for Gastroesophageal Junction Adenocarcinoma
Journal of Surgical Research · 2023
DOI: 10.1016/j.jss.2023.03.047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Research, 2023. Verfasst von Zachary E Stiles und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Adenocarcinoma. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Reported rates of subcarinal lymph node (LN) metastases for esophageal carcinoma vary from 20% to 25% and the relevance of subcarinal lymph node dissection (LND) for gastroesophageal junction (GEJ) adenocarcinoma is poorly defined. This study aimed to evaluate rates of subcarinal LN metastasis in GEJ carcinoma and determine their prognostic significance. METHODS: Patients with GEJ adenocarcinoma undergoing robotic minimally invasive esophagectomy from 2019 to 2021 were retrospectively assessed within a prospectively maintained database. Baseline characteristics and outcomes were examined with attention to subcarinal LND and LN metastases. RESULTS: Among 53 consecutive patients, the median age was 62, 83.0% were male, and all had Siewert type I/II tumors (49.1% and 50.9%, respectively). Most patients (79.2%) received neoadjuvant therapy. Three patients had subcarinal LN metastases (5.7%) and all had Siewert type I tumors. Two had clinical evidence of LN metastases preoperatively and all three additionally had non-subcarinal nodal disease. A greater proportion of patients with subcarinal LN disease had more advanced (T3) tumors compared to patients without subcarinal metastases (100.0% versus 26.0%; P = 0.025). No patient with subcarinal nodal metastases remained disease free at 3 y after surgery. CONCLUSIONS: In this consecutive series of patients with GEJ adenocarcinoma undergoing minimally invasive esophagectomy, subcarinal LN metastases were found only in patients with type I tumors and were noted in just 5.7% of patients, which is lower than historical controls. Subcarinal nodal disease was associated with more advanced primary tumors. Further study is warranted to determine the relevance of routine subcarinal LND, especially for type 2 tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
- Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York. Electronic address: moshim.kukar@roswellpark.org.
Zitieren
APA
Stiles, Z. E., Brady, M., Hochwald, S. N., & Kukar, M. (2023). Relevance of Subcarinal Lymph Node Dissection for Gastroesophageal Junction Adenocarcinoma. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2023.03.047
Vancouver
Stiles ZE, Brady M, Hochwald SN, Kukar M. Relevance of Subcarinal Lymph Node Dissection for Gastroesophageal Junction Adenocarcinoma. Journal of Surgical Research. 2023. doi:10.1016/j.jss.2023.03.047
BibTeX
@article{Stiles2023,
author = {Stiles, Zachary E and Brady, Maureen and Hochwald, Steven N and Kukar, Moshim},
title = {Relevance of Subcarinal Lymph Node Dissection for Gastroesophageal Junction Adenocarcinoma},
journal = {Journal of Surgical Research},
year = {2023},
doi = {10.1016/j.jss.2023.03.047}
}
EUVIMED